Correspondence 0001193125-25-065580 from Tenaya Therapeutics, Inc. (TNYA)
Tenaya Therapeutics, Inc.
Date: March 27, 2025 · CIK: 0001858848 · Accession: 0001193125-25-065580
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286005
Letter
Re: Tenaya Therapeutics, Inc. Registration Statement on Form S-3 Filed March 21, 2025 File No. 333-286005 Acceleration Request Requested Date: March 31, 2025 Requested Time: 4:00 P.M. Eastern Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Tenaya Therapeutics, Inc. (the “ Company ”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-286005) (the “ Registration Statement ”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Jennifer Knapp at (650) 849-3041. Please direct any questions or comments regarding this acceleration request to Jennifer Knapp at (650) 849-3041. [Signature page follows]
March 27, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549-3720
Attention: Joshua Gorsky
Securities and Exchange Commission March 27, 2025 Page 2
Sincerely,
TENAYA THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP March 27, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549-3720 Attention: Joshua Gorsky Re: Tenaya Therapeutics, Inc. Registration Statement on Form S-3 Filed March 21, 2025 File No. 333-286005 Acceleration Request Requested Date: March 31, 2025 Requested Time: 4:00 P.M. Eastern Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Tenaya Therapeutics, Inc. (the “ Company ”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-286005) (the “ Registration Statement ”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Jennifer Knapp at (650) 849-3041. Please direct any questions or comments regarding this acceleration request to Jennifer Knapp at (650) 849-3041. [Signature page follows] Securities and Exchange Commission March 27, 2025 Page 2 Sincerely, TENAYA THERAPEUTICS, INC. /s/ Faraz Ali, M.B.A. Faraz Ali, M.B.A. Chief Executive Officer cc: Jennifer Drimmer Rokovich, J.D., Tenaya Therapeutics, Inc. Jennifer Knapp, Wilson Sonsini Goodrich & Rosati, P.C. Emily A. Coskey, Wilson Sonsini Goodrich & Rosati, P.C.